Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study
- 1 March 2005
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 96 (3) , 705-713
- https://doi.org/10.1016/j.ygyno.2004.10.046
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapyCytokine & Growth Factor Reviews, 2003
- Expression of TRAIL (TNF‐related apoptosis‐inducing ligand) and its receptors in normal colonic mucosa, adenomas, and carcinomasThe Journal of Pathology, 2003
- Targeting death and decoy receptors of the tumour-necrosis factor superfamilyNature Reviews Cancer, 2002
- Criteria for Organized Cervical Screening ProgramsActa Cytologica, 2002
- Fas receptor‐mediated apoptosis: a clinical application?The Journal of Pathology, 2001
- Estimating the world cancer burden: Globocan 2000International Journal of Cancer, 2001
- Cervical Cancer Cells Induce Apoptosis of Cytotoxic T LymphocytesJournal of Immunotherapy, 2000
- Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy ReceptorsScience, 1997
- An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAILScience, 1997
- The Receptor for the Cytotoxic Ligand TRAILScience, 1997